• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

YM976 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5758808

MBS5758808 is an inhibitor targeting YM976. YM976 is an orally active PDE4 inhibitor (IC50:2.2nM) More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
YM976, Inhibitor
Full Product Name
YM976
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
99.84%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
313.78
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C17H16ClN3O
SMILES
CCc1ccc2c(-c3cccc(Cl)c3)nc(=O)n(CC)c2n1
CAS Number
191219-80-4
Target & IC50
PDE4: ic50 2.2nM

Product Categories/Family for YM976, inhibitor

Structure of YM976, inhibitor

YM976 Inhibitor – Cat# MBS5758808

Product References and Citations for YM976, inhibitor

Aoki M, Kobayashi M, Ishikawa J, et al. A Novel Phosphodiesterase Type 4 Inhibitor, YM976 (4-(3-Chlorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one), with Little Emetogenic Activity[J]. Journal of Pharmacology & Experimental Therapeutics, 2000, 295(1):255-260.
Aoki M, Kobayashi M, Ishikawa J, et al. A Novel Phosphodiesterase Type 4 Inhibitor, YM976 (4-(3-Chlorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one), with Little Emetogenic Activity[J]. Journal of Pharmacology & Experimental Therapeutics, 2000, 295(1):255-260.
Aoki M, Yamamoto S, Kobayashi M, et al. Antiasthmatic effect of YM976, a novel PDE4 inhibitor, in guinea pigs[J]. Journal of Pharmacology and Experimental Therapeutics, 2001, 297(1):165-173.
Aoki M, Yamamoto S, Kobayashi M, et al. Antiasthmatic effect of YM976, a novel PDE4 inhibitor, in guinea pigs[J]. Journal of Pharmacology and Experimental Therapeutics, 2001, 297(1):165-173.

Other Notes

Small volumes of YM976, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000